QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening

Published on January 7, 2025

potential investors to explore strategic partnerships and investment opportunities, including discussions about QUANTRO’s current financing

Continue reading on website
Other news

Talen Energy Supply Announces Commencement of Consent Solicitation for Its 8.625% Senior Secured Notes Due 2030

January 7, 2025
among other things, capital expenditures, earnings, litigation, regulatory matters, hedging, liquidity and capital resources and accounting

Beneficient Enters into $1.36 Million GP Primary Capital Transaction

January 7, 2025
announced it has closed on the financing of a $1.36 million primary capital commitment for 8F Fund, LP (“Fund”), a fund managed by 8F Asset